Endoscopic Vacuum Therapy for Anastomotic Leakage After Upper Gastrointestinal Surgery / Endoscopic Vacuum Therapy for Esophageal Perforation: A Multicenter Retrospective Cohort Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The goal of this observational study is to learn about the best indications and techniques regarding endoscopic vacuum therapy (EVT) in patients with a transmural defect in the upper gastrointestinal (GI) tract (e.g. anastomotic leakage, Boerhaave syndrome, iatrogenic perforation, other). The main questions it aims to answer are: * What is the success rate of EVT for transmural defects in the upper GI tract? * What are the best indications for EVT in the upper GI tract? (e.g. etiology, patient characteristics, defect characteristics) * What are the best techniques for EVT in the upper GI tract? (e.g. EsoSponge, VACStent, vacuum pressure, intraluminal/intracavitary) Participants will be asked for informed consent to retrospectively and prospectively collect data on EVT.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• Treated with EVT for anastomotic leakage after esophago-gastric surgery

• Signed informed consent form

• 18 years or older

Locations
Other Locations
Netherlands
Amsterdam University Medical Centers, location VUmc
RECRUITING
Amsterdam
Contact Information
Primary
Roos Pouw, MD, PhD
r.e.pouw@amsterdamumc.nl
+3120 4444444
Backup
Lisanne Pattynama, MD
l.m.pattynama@amsterdamumc.nl
+3120 4444444
Time Frame
Start Date: 2021-10-01
Estimated Completion Date: 2030-10-01
Participants
Target number of participants: 200
Treatments
Anastomotic leakage after gastrointestinal surgery
No interventions will be administered, as this is an observational study.
Esophageal perforation (Boerhaave syndrome, iatrogenic, trauma, other)
No interventions will be administered, as this is an observational study.
Related Therapeutic Areas
Sponsors
Leads: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

This content was sourced from clinicaltrials.gov